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Abstract
Hypersensitivity due to central pain mechanisms can influence recovery and lead to worse clinical outcomes, but the ability of
quantitative sensory testing (QST), an index of sensitisation, to predict outcomes in chronic musculoskeletal disorders remains
unclear. We systematically reviewed the evidence for ability of QST to predict pain, disability, and negative affect using searches of
CENTRAL, MEDLINE, EMBASE, AMED, CINAHL, and PubMed databases up to April 2018. Title screening, data extraction, and
methodological quality assessments were performed independently by 2 reviewers. Associations were reported between baseline
QST and outcomes using adjusted (b) and unadjusted (r) correlations. Of the 37 eligible studies (n 5 3860 participants), 32 were
prospective cohort studies and 5 randomised controlled trials. Pain was an outcome in 30 studies, disability in 11, and negative
affect in 3. Meta-analysis revealed that baseline QST predicted musculoskeletal pain (mean r5 0.31, 95% confidence interval [CI]:
0.23-0.38, n 5 1057 participants) and disability (mean r 5 0.30, 95% CI: 0.19-0.40, n 5 290 participants). Baseline modalities
quantifying central mechanisms such as temporal summation and conditioned painmodulation were associated with follow-up pain
(temporal summation: mean r 5 0.37, 95% CI: 0.17-0.54; conditioned pain modulation: mean r 5 0.36, 95% CI: 0.20-0.50),
whereas baseline mechanical threshold modalities were predictive of follow-up disability (mean r 5 0.25, 95% CI: 0.03-0.45).
Quantitative sensory testing indices of pain hypersensitivity might help develop targeted interventions aiming to improve outcomes
across a range of musculoskeletal conditions.
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1. Introduction
Musculoskeletal disease is a worldwide phenomenon and one of
the most frequent reasons for seeking health care assistance.60
Pain is paramount in a range of symptoms associated with
musculoskeletal pathology, which contributes to functional
limitation.80,102 The most prevalent musculoskeletal conditions
that transition into chronicity include osteoarthritis (OA), low back
pain (LBP) or neck pain, and rheumatoid arthritis.11 Chronic pain
may be initiated by musculoskeletal pathology, but is frequently
also augmented by modulation of sensory inputs by the
peripheral nervous system and central nervous system
(CNS).9,22,67,82,93
Central sensitisation refers to neurophysiological processes
that can occur throughout the CNS leading to changes in the
spinal cord as well as in supraspinal centres such as the
brainstem, the cerebral cortex, the thalamus, and the limbic
system.52 Central sensitisation is implicated in pain chronification,
manifested by pain hypersensitivity (augmentation), and spread
to sites beyond those directly affected by musculoskeletal
pathology.109 Sustained activation of peripheral nociceptive
pathways due to musculoskeletal pathology (eg, trauma or
inflammation) drives pain hypersensitivity,31 which may be
maintained by neuroplastic changes in the CNS.76 Pain
hypersensitivity is influenced by physical, genetic, psychological,
and environmental factors.79 Researchers have suggested that
cognitive factors such as maladaptive beliefs (catastrophising,
fear of movement, and expectations of treatment outcomes)
might contribute to pain hypersensitivity.101,113 Pain-specific
cognitions such as catastrophisation influence endogenous pain
modulation in healthy participants.100 The presence of pain
hypersensitivity complicates the clinical picture of chronic
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musculoskeletal conditions,69 may cause or contribute to the
transition from acute to chronic pain, and may be a barrier to
achieving optimal treatment outcomes.26,34,51
Clinically important pain hypersensitivity is not present in all
individuals with chronic pain,90,109 contributing to heterogeneity
in prognosis and treatment outcomes. It has been suggested that
people with centrally driven pain hypersensitivity might better
respond to education, exercise, and cognitive behavioural
therapy than to treatments focusing on reducing nociceptive
triggers alone.53,65,66
Detection and measurement of hypersensitivity is challenging
in human research and clinical practice, and there is no
consensus yet on the most appropriate tools for use in chronic
musculoskeletal pain.33,63 Identifying optimal indices of hyper-
sensitivity is required to develop targeted treatment strategies
that can improve patient outcomes. Self-report questionnaires
may identify risk factors and symptoms that are commonly
associated with central sensitisation.3 Qualities of pain in people
with central sensitisation, however, overlap substantially with pain
qualities in people with predominant nociceptive pain mecha-
nisms. Quantitative sensory testing (QST) is a psychophysical
approach through which stimuli are applied under standardised
testing protocols, and the participants’ self-reported sensory
experience is quantified.38 Quantitative sensory testing can
explore mechanisms responsible for the development or main-
tenance of local and widespread pain in musculoskeletal
disorders.20,74 Quantitative sensory testing uses simple tools for
the assessment of the perception of touch, vibration, pro-
prioception, and pinprick/blunt pressure sensitivity or sensitivity
to cold or heat stimuli.21 The various QST modalities can provide
important information about pain mechanisms,6,20 and can be
used to quantify sensory alterations to healthy individuals and
patients alike.85 However, the exact neurophysiological mecha-
nisms that underline QST responses are not yet fully established.
The predictive capacity of QST has been previously explored in
nonmusculoskeletal pain states. Baseline sensory measure-
ments have been associated with analgesic consumption in
patients with chronic pancreatitis73 and in healthy individuals with
experimental pain,29 with the clinical course of painful temporo-
mandibular disorder,89 and with tension-type headaches.13 In
musculoskeletal conditions, QST measures before surgery have
been associated with acute postoperative outcomes2,27,86,107;
however, the capacity of QST to predict long-term postoperative
outcomes and outcomes in nonsurgical contexts has not been
fully investigated. Potential influences from QST modality and
musculoskeletal diagnosis, and prediction of different pain-
related experiences, such as pain severity, reduced functional
capacity (disability), anxiety, and depression (negative affect)91
remain uncertain. A greater understanding of the role of pain
hypersensitivity in prognosis and how QST might predict
musculoskeletal outcomes should help better predict those
who are most likely to gain benefit from treatments aiming to
reduce ongoing pain, distress, or disability.
We used systematic literature review and meta-analysis to
primarily determine the ability of QST to predict musculoskeletal
outcomes in unadjusted analyses. In secondary analyses, we
explored possiblemechanisms underlying prediction by adjusting
for other covariates and confounders.
2. Methods
The present systematic review adheres to an a priori but not
publicly registered protocol.
2.1. Systematic literature search
A systematic online search was conducted in the following
databases: CENTRAL, MEDLINE, EMBASE, AMED, CINAHL,
and PubMed from 1948 until April 2018. In the absence of
a previously standardised search strategy for QST and muscu-
loskeletal conditions, a unique strategy (Appendix 1, available as
supplemental digital content at http://links.lww.com/PAIN/A787)
was based on previous systematic reviews. The QST elements of
the search strategywere adapted froma systematic review on the
utilisation of QST in painful OA,98 and the musculoskeletal
components were adapted from a systematic review on
musculoskeletal intervention and imaging.32 The search strategy
was not limited to a specific study design to maximise the
potential to retrieve relevant studies and because statistical
association analysis can be frequently found in randomised
controlled trials (RCTs) as well as in prospective cohort studies. A
list of the search terms and their combinations that were used in
the aforementioned databases is demonstrated in Appendix 1
(available as supplemental digital content at http://links.lww.com/
PAIN/A787). Citation tracking from identified studies as well as
from relevant reviews was also used to maximise the efficiency of
the search strategy. No contact of authors to retrieve missing
data was attempted.
2.2. Inclusion/exclusion criteria
We operationally defined QST as a method that attempts to
measure, in a quantifiable way, responses to sensory stimuli
applied on the skin with the aim to be used as an indicator of
altered pain sensitivity. Studies that featured QST in their
methodology were considered for inclusion in the systematic
literature review only if they satisfied the criteria summarised in
Table 1. All identified studies were downloaded and imported to
Table 1
Study eligibility criteria.
Inclusion criteria
1. Prospective studies that had recruited adult participants with any musculoskeletal condition and had used QST to predict a longitudinal outcome.
2. QST modalities used one or more of chemical, electrical, mechanical, and/or thermal stimuli applied to skin, muscle, or joint
3. Univariate, bivariate, or multivariate statistical relationship between QST and outcomes reported, or report data that allow such calculation.
4. QST protocol describes stimulus modality, anatomical site, and intensity.
5. Published in English language as an original research article in a peer-reviewed journal.
Exclusion criteria
1. Studies reporting only cross-sectional data.
2. Duplicate publication of data (follow-up analysis of already published data).
3. Books or book chapters, PhD theses or other dissertations, and abstracts of conference presentations.
QST, quantitative sensory testing.
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EndNote X8 (Thomson Reuters) where the duplicates were
removed. Two reviewers independently undertook the two-phase
screening process. Phase one (V.G. and D.A.W.), was the
evaluation of the titles and abstracts of the identified studies,
whereas phase 2 (V.G. and K.A.-A.) consisted of full-text retrieval
of all studies deemed eligible for inclusion at the end of phase one.
2.3. Data extraction
To increase reliability, 2 independent reviewers (V.G. and K.A.-A.)
extracted the data from included studies using a bespoke
spreadsheet. Data were extracted on study design, setting,
sample selection, length of follow-up, musculoskeletal condition,
affected joint or body part, diagnostic criteria, demographic data
(mean age, sex and number of participants), pain severity at
baseline and at follow-up, stimulus protocol, QST modalities and
outcome measures, and the anatomical site of QST. Correlation
coefficient (r), regression coefficient (b), odds ratios (ORs), area
under the curve, and x2 values were collected along with their P-
value, SD, SE and 95% confidence interval (CI). We adhered to
suggestions by Hayden et al.40 and, when data were extracted
from a regression model, the prognostic factors that the derived
value was adjusted for were also extracted (Appendix 2, available
as supplemental digital content at http://links.lww.com/PAIN/
A787). In all cases of disagreement on the extracted data or their
interpretation, consensus was achieved through discussion,
whenever necessary including all authors.
2.4. Quality and content assessment
The quality of included studies was appraised by the Quality In
Prognosis Studies (QUIPS) Tool41 for observational cohort
studies as well as RCTs.
2.5. Data synthesis and analysis
Coding of the data was conducted by one reviewer (V.G.) and was
validated by one coinvestigator (D.F.M.). Data from included
studies were primarily categorised according to association values
featured in the studies: r-correlation coefficients (unadjusted
correlation) and b-coefficients (adjusted correlation). All extracted
OR values were log-transformed to b-coefficients with the use of
RevMan 5 (Review Manager. Version 5.3. Copenhagen: The
Nordic Cochrane Centre, The Cochrane Collaboration, 2014) and
were therefore fitted in the adjusted correlation data cohort. Data
were further subdivided according to themusculoskeletal outcome
(pain, disability, and negative affect) measured in the study and,
given sufficient data, separate meta-analysis was conducted for
each outcome. When a study used a single outcome measure to
observe more than one outcome (eg, pain and disability), then we
categorised the data according to which outcome the tool was
prioritising. If therewas an equalweight onboth outcomes, thenwe
included the data on both subsets. In secondary, exploratory
analyses, data were further subgrouped according to study design
(RCT or prospective cohort) and QSTmodalities based on the type
of stimulation such as mechanical (pressure/punctate detection or
tolerance threshold with algometers, von Frey monofilaments, or
pinpricks), thermal (cold–hot detection or pain thresholds),
movement (pain provocation testing), and electrical (detection or
pain thresholds). For the purposes of this review, we further
subclassified QST modalities as “static” and “dynamic,” with static
modalities including pain detection and tolerance thresholds, and
dynamic modalities investigating changes in certain mechanisms
of pain processing with specialised stimulation (descending pain
modulation, temporal and spatial summation).6 All QST and
outcome measurements were extracted at baseline and sub-
sequent follow-ups. If different QST application sites were
reported, data were extracted for all and grouped into local, distal,
and remote to the affected joint sites. We defined as local site the
primary area of clinical pain (knee, neck, lowback, shoulder, elbow,
and hip). Distal sites (eg, tibialis anterior in knee OA) were in the
same limb as the musculoskeletal pathology, and distant sites
were elsewhere in the body.
Forest and funnel plots were developed from pooled data of
comparable studies by using a random-effectsmodel of analysis in
R (meta package, R Core Team 2017, Austria). To increase the
sample size of themodel and allow for more rigorous analysis, data
were pooled for meta-analysis only where there were at least 3
eligible studies. When a single study reported both correlation and
regression coefficients, both values were used in separate meta-
analysis models. In cases where a single study reportedmore than
one result from the same analytical approach (unadjusted
correlation or adjusted correlation), the stronger association value
was incorporated into the model.48 If associations were of similar
strength, the statistically significant value (P, 0.05) was preferred
for analysis, usually indicating the larger numbers of participants. In
situations where unadjusted and adjusted b-coefficient values
were reported, we incorporated only the adjusted values in the
models.4 When multiple associations from the same study were
statistically significant, we included the one related to the most
clinically relevant aspect of the outcome (worst pain or pain with
movement). Single studies that examined the relationship of QST
and outcome in 2 different musculoskeletal conditions were
subdivided into 2 separate studies for the purposes of statistical
analysis and were included in the same model.
Pearson’s r or Spearman’s rwere included in the samemodels
and were z-transformed during the analysis to normalise the
sampling distribution of unadjusted correlation (r) and decrease
the bias of the average correlation.17 Given the variability in study
design, QST modalities, and follow-up outcome measures,
statistics to test the null hypothesis of statistical validity
(Cochran’s Q test) and to quantify the percentage of variance
attributable to study heterogeneity rather than chance (I2 statistic)
were calculated and reported for each forest plot.47 Where
statistically significant, heterogeneity was determined by an I2
value with an associated P-value of ,0.1. I2 values of 25% were
considered as low heterogeneity, of 50% as moderate, and of
75% as high.47 As per study protocol, we a priori considered
a cutoff I2 value of 50% to perform subgroup analysis with
subgroups defined based on methodological quality, QST
application site (local vs distal or distant), musculoskeletal
condition, QST protocol, and QST modality. Based on levels of
heterogeneity and where there were sufficient data, further post
hoc exploratory analyses were permitted. The post hoc analyses
reported here explore relationships between baseline QST and
follow-up pain according to different QST stimulus within specific
modalities, site of clinical pain (axial or peripheral), study design,
and studies that in their regression models had adjusted for
baseline pain. Data were converted when necessary to ensure
that higher numerical QST values reflected greater sensitivity.
To assess for publication bias, funnel plots were developed
and to assess funnel plot asymmetry, Egger test was per-
formed.28 Judging overall risk of bias for each study is
recommended where judgments can be made within a specific
context such as developing clinical practice guidelines46 or for
undertaking sensitivity analyses.42 The overall risk of bias for both
study designs was determined to allow combined subgroup
analyses according to levels of bias (high,moderate, and low).We
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a priori set study confounding and appropriate statistical analysis
as themost important domains for QUIPS.41 The likely magnitude
and direction of bias was considered for an overall judgement
whenever there was a different measurement of bias between
domains of the same tool.46 All discrepancies were discussed
between the 2 reviewers (V.G. and K.A.-A.), and the overall risk of
bias was determined through consensus.
For interpretation purposes, the strength of any unadjusted
association was considered little or zero, fair, moderate to good,
and good to excellent when r valueswere between 0.00 and 0.25,
0.25 to 0.50, 0.50 to 0.75, and .0.75, respectively.81
Thecriteria for exclusion from themeta-analysiswere theabsence
of unadjusted or adjusted correlation data. The present article was
composed under the guidelines of the Preferred Reporting Items for
Systematic reviews and Meta-Analyses (PRISMA).55
3. Results
3.1. Characteristics of included studies
The study selection process is shown in Figure 1 (37 studies),
a summary of the study characteristics in Table 2, and an
overview of study data in Appendix 3 and 4a, b, c (available as
supplemental digital content at http://links.lww.com/PAIN/
A787). Of the 37 studies that met the inclusion criteria,
321,10,16,19,23–25,35,37,49,54,56,57,59,62,70,75,77,78,83,94,95,97,99,104–
106,108,110–112 were prospective cohort studies and 5 were
RCTs.5,18,43,50,61 The total number of participants was 3810, of
whom277were inRCTs.Womencomprised58%of all participants,
and the average age of participants in each study ranged from 36 to
72 years (Table 2). Interventions offered in the RCTs were non-
steroidal anti-inflammatory drugs,5 cervical and shoulder manipula-
tion,18 exercise therapy,43 transcranial magnetic stimulation,61 and
a combination of analgesic medication, physiotherapy, education,
and psychological support.50 Knee OA was the most commonly
studied condition (13/37 studies), and postoperative pain after
thoracotomy, subacromial decompression, total hip replacement or
total knee replacement, and abdominal surgery comprised the
second commonest condition (8/37). The remaining studies focused
on whiplash-associated disorders (WAD) (6/37), LBP (4/37),
shoulder pain (3/37), epicondylitis (1/37), fibromyalgia (1/37), and
anterior cruciate ligament tear (1/37).
Thirty-four studies reported data that could be included in meta-
analysis; 22 studies reported correlation coefficients, and 24 studies
reported b-coefficients or ORs. Two studies each reported on either
2 separate conditions (LBPandneckpain) or 2 interventions (total hip
replacement and total knee replacement) and each provided data for
their different populations that allowed fitting within a single meta-
analysis model. All 37 identified studies demonstrated good
methodological quality with most of them (25/37) displaying low risk
of bias (Appendix 5, available as supplemental digital content at
http://links.lww.com/PAIN/A787). Out of the 34 studies included in
meta-analysis models, 24were considered of low risk of bias and 10
of moderate risk (Appendix 5, available as supplemental digital
content at http://links.lww.com/PAIN/A787).
3.2. Quantitative sensory testing modalities, outcomes, and
test sites
The majority of the studies (30/37) reported on more than one
QST modality. Mechanical pressure (assessed by various
pressure algometers) was the most common stimulus (26/37),
followed by cold (15/37), heat (14/37), and punctate (pinprick:
5/37, von Frey monofilaments 3/37) stimuli. Nearly all studies
(32/37) reported pain detection and tolerance thresholds as
a QST outcome. Conditioned pain modulation (CPM) (12/37),
temporal summation (TS) (8/37), pain intensity (8/37), sensation
detection threshold (6/37), and spatial summation (1/37) was
each reported in a minority of studies. Most publications reported
Table 2
Summary of study characteristics.
Cohort RCT All studies
No. Studies 32 5 37
No. Subjects 3583 277 3860
Mean age (y) 55 54 55
Female, % 56 72 58
Setting
Hospital 6 2 8
Community 6 2 8
Unclear 20 1 21
Diagnosis
OA 15 2 17
MSK injury 1 0 1
Whiplash 5 1 6
Neck pain 1 0 1
Low back pain 4 0 4
Fibromyalgia 0 1 1
Shoulder pain 3 1 4
Postoperative pain 3 0 3
Affected site
Knee 15 2 17
Hip 1 0 1
Neck 6 1 7
Low back 4 0 4
Shoulder 3 1 4
Thorax 1 0 1
Abdominal area 2 0 2
Widespread body pain 0 1 1
MSK outcome measure
Pain 26 4 30
Disability 10 1 11
Depression 2 0 2
Anxiety 1 0 1
QST stimulus modality*
Mechanical
Pressure 21 5 26
Punctate 8 0 8
Movement 1 0 1
Electrical 5 1 6
Thermal
Heat 13 1 14
Cold 14 1 15
QST outcome measure*
Pain detection threshold 28 4 32
Pain tolerance threshold 6 0 6
Sensation detection threshold 5 1 6
Pain intensity 8 0 8
Conditioned pain modulation 11 1 12
Temporal summation 5 3 8
Spatial summation 1 0 1
QST test sites*
Affected joint 20 4 24
Distal to affected joint 10 3 13
Remote 20 3 23
* One study may involve more than one QST modality, outcome measure, and test site.
MSK, musculoskeletal; OA, osteoarthritis; RCT, randomised controlled trial; QST, quantitative sensory testing.
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more than one anatomical site for QST assessment (Appendix 3,
available as supplemental digital content at http://links.lww.com/
PAIN/A787). The commonest were the site of clinical pain (24/37),
followed equally by sites that were distal to (13) or remote from
(13) the site of reported pain.
3.3. Reliability of quantitative sensory testing
Four studies49,59,75,110,112 reported that QST applications were
performed by the same individual but did not report test–retest
reliability. One study19 referenced a previous study to report QST
reliability. Only 1 of the 37 studies83 reported intraclass correlation
coefficient for test–retest and interrater reliability with values 0.92
to 0.97 for mechanical pain sensitivity, 0.70 to 0.92 for heat pain
threshold, and 0.87 to 0.97 for pressure pain detection threshold
(PPT). In 2 studies,5,54 assessments were conducted by multiple
individuals but no intraclass correlation coefficient or interob-
server variability was reported. One of the studies54 reported that
this as a methodological limitation.
3.4. Ability of quantitative sensory testing to predict
outcomes in people with musculoskeletal conditions
Baseline QST demonstrated a statistically significant association
with worse musculoskeletal-related outcomes (pain or disability)
in 35 of the 37 studies (Appendix 3, available as supplemental
digital content at http://links.lww.com/PAIN/A787). Presentation
of associations varied between studies as Pearson’s r, b-coef-
ficients, ORs, area under the curve, and x2. Several stud-
ies24,25,35,61,75,77,78,104,105,112 reported both correlation-
coefficient and regression-coefficient values. Two studies59,70
narratively reported (without presenting data) no observed
correlation between baseline QST, measured using mechanical
and thermal modalities (sensitivity and pain threshold) and follow-
up pain. Five other studies used mechanical stimuli5,49,78,112 or
electrical stimuli,99 but presented data only partially, favouring
data that supported association.
Twenty-five studies reported regression analyses, of which 22
reported baseline factors used for statistical adjustment. Appendix
2 describes these 22 studies, their outcomes, and the factors they
adjusted for (available as supplemental digital content at http://
links.lww.com/PAIN/A787). Pain alone was the outcome in 13/22
and disability alone in 6/22. Both pain and disability were reported
in 2/22, and disability and negative affect were reported together in
1/22. Fifteen studies reported baseline pain scores, of which 11
adjusted outcomes for baseline pain, and 4 for factors other than
pain measured at baseline (pain catastrophising, depression, age,
sex, ethnicity, analgesia requirement, pain duration, and genetic
factors). Adjustment for baseline disability was reported in 3/9 of
the studies reporting disability as an outcome. The single study that
measured negative affect did not adjust for baseline negative affect.
3.5. Outcome prediction by baseline quantitative sensory
testing (primary analysis)
3.5.1. Prediction of clinical pain by baseline quantitative
sensory testing
Unadjusted (r) correlation data were available from 18 studies that
permitted meta-analysis examining the ability of QST to predict
follow-up pain. The pooled unadjusted r value among the included
studies was 0.31 (95% CI: 0.23-0.38) (Fig. 2). I2 calculations
indicated 36% of heterogeneity (P 5 0.07). Funnel plot for studies
reporting unadjusted correlations were symmetrical, suggesting little
or no bias (the Egger test521.0, P5 0.32) (Fig. 3A).
Subgroup analyses according to risk of bias showed that
unadjusted correlations for studies with low (r 5 0.28, 95% CI:
0.19-0.38; I25 53%, P5 0.01) and moderate (r5 0.34, 95% CI:
0.17-0.48; I2 5 0%, P 5 0.50) risk of bias were similar to those
reported in Figure 2.
Seven studies25,43,49,61,78,103,110 reported unadjusted corre-
lation data between baseline QST and change in pain as
observed between 2 time points (baseline and follow-up). When
pooled, they yielded an overall r 5 0.32 (95% CI: 0.19-0.44) and
heterogeneity of 29% (P 5 0.21).
3.5.2. Prediction of disability by baseline quantitative sensory
testing
Eleven studies1,16,19,24,50,75,94,95,97,104,105 reported disability out-
comes and most of these (7/11) included participants with WAD.
Meta-analysis revealed a mean unadjusted correlation between
baseline QST and disability outcome of 0.30 (95% CI: 0.19-0.40)
(Fig. 4). I2 calculations indicated heterogeneity of 0% (P5 0.72) for
the unadjusted correlation subset. Funnel plot and the Egger test
did not show significant asymmetry for the unadjusted data set (the
Egger test 5 20.10, P 5 0.93) (Appendix 6, available as
supplemental digital content at http://links.lww.com/PAIN/A787).
Subgroup analyses according to risk of bias showed that
studies with low risk of bias yielded similar unadjusted correlation
(r5 0.30, 95%CI: 0.18-0.41; I25 0%,P5 0.51) to the correlation
reported in Figure 4. Meta-analysis of unadjusted correlation
data from the small number of studies with moderate risk of bias
was not feasible for disability.
3.5.3. Prediction of negative affect by baseline quantitative
sensory testing
Three studies35,94,104 examined whether QST can predict pain-
related negative affect (depression or anxiety), of which 2
studies35,94 reported statistically significant prediction of depres-
sion and posttraumatic stress disorder (Appendix 3, available as
supplemental digital content at http://links.lww.com/PAIN/A787).
3.5.4. Effect of study design on outcome prediction by
baseline quantitative sensory testing
Post hoc subgroup analyses for unadjusted correlations and
heterogeneity were similar for cohort studies (r 5 0.31, 95% CI:
0.24-0.38; I25 14%, P5 0.30) as for RCTs (r5 0.27, 95% CI:2
0.02 to 0.52; I2 5 73%, P 5 0.01), and therefore similar to the
overall models presented in Figure 2.
3.5.5. Effect of quantitative sensory testing anatomical site
on outcome prediction by baseline quantitative sensory
testing
We tested the levels of association between QST application site
(sites of pathology or remote) and pain. Subgroup analyses of
unadjusted correlation data for application of QST at the site of
pathology showed r50.30, 95%CI: 0.22-0.38; I2543%,P50.03.
Unadjusted correlation data for application of QST at a remote site
showed r50.19, 95%CI: 0.07-0.30; I2523%,P50.27. Pooling of
distal site data for subgroup analysis was not feasible.
3.5.6. Effect of quantitative sensory testing modality on
outcome prediction by baseline quantitative sensory testing
Multiple subgroups were analysed to examine whether specific
QST modalities (or similar groups of those) could predict follow-up
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pain or pain-related disability (Table 3). In terms of pain, the pooled
unadjusted correlation results between static modalities such as
pain detection threshold (mechanical, thermal, and electrical) and
clinical pain outcomeswere lower (0.20) than the 0.31 presented in
Figure 2 yielding a range from 0.14 to 0.20 and I2 values of 0%.
PPTdemonstrated a pooled unadjusted correlation (r) of 0.20 (95%
CI: 0.11-0.29) and heterogeneity of 0% (P 5 0.57). Higher pooled
unadjusted correlation values were given by TS (0.37, 95% CI:
0.17-0.54) and CPM alone (0.36, 95% CI: 0.20-0.50) and by
a model including only dynamic modalities (CPM and TS) (0.38,
95% CI: 0.26-0.49) with displayed heterogeneity of 69% (P 5
0.02), 43% (P5 0.12), and 53% (P5 0.02), respectively. Post hoc
subgrouping of CPM according to conditioning stimulus (cold
water immersion), and subgrouping of predictive capacity in axial
(LBP and Neck pain) or peripheral (OA) pathologies yielded similar
pooled unadjusted correlations as those presented in Table 3.
Conditioned pain modulation–related post hoc subgroup analyses
displayed either complete absence (0%) or nonstatistically
significant (P. 0.05) heterogeneity. Pooling of TS data according
to type of stimulus for post hoc subgroup analysis was not feasible.
Insufficient data precluded also meta-analysis of unadjusted
correlation values for disability outcomes.
3.6. Adjusted associations of musculoskeletal outcomes
with baseline quantitative sensory testing
(secondary analyses)
3.6.1. Association of clinical pain with baseline quantitative
sensory testing
Adjusted (b) correlation data were also available from 18 studies
that permitted meta-analysis examining the association of
baseline QST with follow-up pain when other variables are taken
into account. The pooled adjusted correlation among the
included studies was 0.18 (95% CI: 0.11-0.25) out of which, in
post hoc analysis, studies that adjusted for baseline pain (13/18)
displayed a pooled adjusted correlation of 0.13 (95% CI: 0.06-
0.20). I2 calculations indicated 69% heterogeneity (P , 0.01) for
the adjusted correlation data set and 72% (P , 0.01) for the
subset that adjusted for baseline pain. Funnel plots for adjusted
correlations deviated to the right (0.00-2.22) (the Egger test 5
10.0, P , 0.0001) (Fig. 3B), indicating publication bias.
Subgroup analyses according to risk of bias showed that
adjusted correlation for studies with low risk of bias were similar (b
5 0.12, 95%CI: 0.06-0.18; I25 61%,P, 0.01) to those reported
in Figure 2 but higher (b 5 0.43, 95% CI: 0.21-0.65; I2 5 32%,
P 5 0.22) for studies with moderate risk of bias.
3.6.2. Association of disability with baseline quantitative
sensory testing
Meta-analysis revealed a mean adjusted correlation between
baseline QST and disability outcome of 0.35 (95% CI: 0.21-0.49)
with I2 calculations yielding heterogeneity of 59% (P5 0.01) (Fig.
4). Funnel plot and the Egger test indicated significant asymmetry
for the adjusted data set (the Egger test 5 4.3, P , 0.01)
(Appendix 6, available as supplemental digital content at http://
links.lww.com/PAIN/A787).
Subgroup analyses according to risk of bias showed that
studies with low risk of bias yielded similar pooled adjusted
correlation (b5 0.35, 95% CI: 0.18-0.52; I25 64%, P, 0.01) to
the correlation reported in Figure 4. Meta-analysis of adjusted
correlation data from studies with moderate risk of bias was not
feasible for disability.
Figure 1. PRISMA flowchart of the study selection process.
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3.6.3. Effect of site of clinical pain on association with
baseline quantitative sensory testing
Multiple subgroup analyses according to musculoskeletal condi-
tion revealed similar pooled adjusted correlation for OA (b 5 0.30,
95%CI: 0.18-0.42; I25 0%, P5 0.89), higher adjusted correlation
for LBP (b 5 0.46, 95% CI: 0.16-0.75; I2 5 0%, P 5 0.72), and
lower adjusted correlation for postoperative pain (b 5 0.13, 95%
CI: 0.02-0.24; I25 77%, P, 0.01). Meta-analysis of the subgroup
of studies reporting an association between baseline QST and
WAD-related disability indicated an adjusted correlation of 0.47
(95% CI: 0.18-0.76) and significant heterogeneity (I2 5 74%, P ,
0.01). Post hoc subgroup analysis was also performed to explore
the degree of association betweenQST and clinical pain according
to its anatomical site because adjusted correlation data were
available both for peripheral joint and axial pain. Models for
adjusted correlation were similar for peripheral joint pain (b5 0.22,
95% CI: 0.12-0.32) as for axial pain (b5 0.22, 95% CI: 0.00-0.43)
and therefore similar to the overall models presented in Figure 2.
Heterogeneity in the axial pain model (I2 5 49%, P 5 0.08) was
slightly lower than for peripheral joints (I2 5 73%, P 5 ,0.01).
3.6.4. Effect of quantitative sensory testing modality on
association with baseline quantitative sensory testing
Pooled adjusted correlation results between static modalities
such as pain detection threshold (mechanical, thermal, and
electrical) and clinical pain outcomes approximated the 0.20
presented in Figure 2, yielding a range from 0.13 to 0.17 and I2
values from 68% to 74% (Table 3). PPT as a stand-alonemodality
demonstrated a pooled adjusted correlation (b) of 0.14 (95% CI:
0.05-0.23) and heterogeneity of 72% (P, 0.01). Pooled adjusted
correlation values by CPMalone (0.35, 95%CI: 0.15-0.54) and by
a model including only dynamic modalities (CPM and TS) (0.33,
95% CI: 0.19-0.47) yielded higher values than those in the overall
models in Figure 2. Both analyses displayed heterogeneity of 0%
(P 5 0.41 and 0.80, respectively).
For studies reporting disability as the clinical outcome,
subgroup analysis of thermal pain detection threshold modalities
showed a pooled adjusted correlation of 0.37 (95% CI: 0.16-
0.58), and the subset using cold as the thermal stimulus revealed
pooled adjusted correlation for cold pain detection threshold of
0.48 (95% CI: 0.19-0.77). Both subgroups showed statistically
Figure 2. Forest plots showing the overall association (r-correlations and b-coefficients) between QST and follow-up pain. CI, confidence interval; CPM,
conditioned pain modulation; CPT, cold pain detection threshold; DNIC, diffuse noxious inhibitory control; EPT, electrical pain threshold; EST, electrical sensation
threshold; MEP, motor-evoked potentials; Observ., observational cohort study; PDT, pressure detection threshold; PPT, pain pressure detection threshold; QST,
quantitative sensory testing; RCT, randomised controlled trial; TS, temporal summation. Forest plot showing the pooled unadjusted (0.31, 95%CI: 0.23-0.38) and
adjusted correlation (0.18, 95% CI: 0.11-0.25) of QST modalities with musculoskeletal pain. The unadjusted correlation plot has been derived through the
incorporation of correlation-coefficient data (Pearson’s or Spearman’s r) expressing a univariate association unadjusted by other factors, whereas the adjusted
correlation plot has been derived through the incorporation of b-coefficient data from linear or logistic regressions expressing a multivariate association.
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significant heterogeneity (P 5 ,0.01) with I2 scores of 69%
and 74%.
4. Discussion
This systematic review and meta-analysis demonstrates a pre-
dictive relationship between baseline QST, a measure of pain
hypersensitivity, andmusculoskeletal pain and disability at follow-
up. This is demonstrated across multiple musculoskeletal
conditions (OA, LBP, WAD, and postoperative pain) affecting
different anatomical sites (knee, hip, low back, neck, and
shoulder), and across different QST modalities and study
contexts (cohort studies and RCTs). The results of this review
show that pain hypersensitivity predicts prognosis. Quantitative
sensory testingmight help identify people who couldmost benefit
from interventions aiming to improve pain and disability.
Previous systematic reviews have been less conclusive on the
ability of QST to predict longitudinal outcomes in patients with
peripheral musculoskeletal conditions, healthy volunteers, surgi-
cal patients, and patients with chronic pain.36,72,86 The present
systematic review extends these reports by demonstrating
longitudinal prediction of several outcomes across a range of
musculoskeletal conditions, and addressing through meta-
analysis the limited power of individual studies. We found that
QST might predict other outcomes beyond pain and disability
such as depression in people with musculoskeletal pain.
Depression and chronic pain may share similar brain activation
pathways as shown by magnetic resonance imaging,39,64,88 and
shared mechanisms might explain shared predictive factors.
Future studies might explore whether QST can predict additional
outcomes such as ability to self-care or absenteeism/
presenteeism. Our findings also indicate that prediction of poor
outcomes by QST evidence of pain hypersensitivity is not disease
specific, applying similarly to axial and nonaxial musculoskeletal
pain. Quantitative sensory testing can also predict acute post-
operative pain.2,27,107
Figure 3. Funnel plots for QST studies (n5 18) examining the capacity of pain hypersensitivity (as measured by QST) to predict or associate with pain at follow-up
depicting (A): unadjusted (r-correlation) datawith little or no indication of publication bias due to their symmetrical presentation and (B): adjusted (b-coefficient) data
with an indication of publication bias due to asymmetry. The axes on both graphs are different scales. QST, quantitative sensory testing.
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Wedidnot findsignificant differences inoutcomepredictionbyQST
between data from cohort studies and those from RCTs, supporting
generalisation of conclusions from our findings. Treatments received
by participants might be similar between cohort studies and RCTs,
and generalisation of our findings to other treatment contexts should
be cautious. Future research might explore whether baseline QST
evidence of hypersensitivity can predict good response to novel
treatments that more effectively reverse hypersensitivity.
Our primary purpose was to investigate outcome prediction in
people with musculoskeletal pain. Those destined to experience
worse outcomes stand to gain more from effective interventions.
Predictors of poor outcomes might also shed some light on
mechanisms and potential targets for interventions aiming to
improve outcome. Univariate prediction is important for identify-
ing people at risk of poor outcome, but provides only very limited
mechanistic understanding. Multiple regression provides greater
insight into causal relationships by adjusting for other factors to
reduce confounding40,58 and bias.41,44 Outcome prediction by
QST seemed stronger in unadjusted than in adjusted correlation
analyses, but the magnitude of these 2 values should not be
Figure 4. Forest plot showing the overall association (r-correlations and b-coefficients) between QST and follow-up disability in musculoskeletal conditions. CI,
confidence interval; CPM, conditioned pain modulation; CPT, cold pain detection threshold; EPT, electrical pain threshold; HNCS, heterotopic noxious
counterstimulation; Observ., observational cohort study; PPT, pain pressure threshold; QST, quantitative sensory testing; RCT, randomised controlled trial; THPR,
tonic heat pain response. Forest plot showing the pooled unadjusted (0.30, 95% CI: 0.19-0.40) and adjusted correlation (0.35, 95% CI: 0.21-0.49) of QST
modalities with musculoskeletal disability. The unadjusted correlation plot has been derived through the incorporation of correlation-coefficient data (Pearson’s or
Spearman’s r) expressing a univariate association unadjusted by other factors, whereas the adjusted correlation plot has been derived through the incorporation of
b-coefficient data from linear or logistic regressions expressing a multivariate association.
Table 3
Associations between QST modalities and pain or disability.
QST modality Clinical outcome No. of studies Sample size Overall correlation 95% confidence intervals I2 I2 P-value
Unadjusted correlation (r ) PDT (all)* Pain 10 576 0.19 0.10 to 0.27 0% 0.75
PDT (mechanical) Pain 9 503 0.20 0.11 to 0.28 0% 0.73
PDT (thermal) Pain 5 298 0.16 0.04 to 0.27 0% 0.88
PPT Pain 7 466 0.20 0.11 to 0.29 0% 0.57
HPT Pain 4 207 0.14 0.00 to 0.27 0% 0.82
CPM Pain 6 282 0.36 0.20 to 0.50 43% 0.12
TS Pain 4 380 0.37 0.17 to 0.54 69% 0.02
Dynamic mods† Pain 9 943 0.38 0.26 to 0.49 53% 0.03
PDT (all) Disability 3 213 0.25 0.03 to 0.45 63% 0.07
Adjusted correlation (b) PPT Pain 11 1378 0.14 0.05 to 0.23 72% ,0.01
CPT Pain 3 279 0.14 20.10 to 0.37 68% 0.04
CPM Pain 5 413 0.35 0.15 to 0.54 0% 0.41
TS Pain 3 450 0.26 0.08 to 0.44 0% 0.83
Dynamic mods† Pain 7 716 0.33 0.19 to 0.47 0% 0.80
PDT (all) Pain 13 1488 0.17 0.08 to 0.26 68% ,0.01
PDT (thermal) Pain 4 461 0.13 20.01 to 0.30 74% 0.01
PDT (all) Disability 8 1195 0.35 0.16 to 0.55 63% ,0.01
PDT (thermal) Disability 7 1127 0.37 0.16 to 0.58 69% ,0.01
CPT Disability 6 685 0.48 0.19 to 0.77 74% ,0.01
PPT Disability 3 256 0.02 20.01 to 0.05 86% ,0.01
* PDT (all) includes all pain detection threshold modalities such as pain pressure detection threshold, pain pressure tolerance threshold, electrical pain threshold, cold pain detection threshold, and heat pain detection threshold.
† Dynamic modalities include conditioning pain modulation and temporal summation data taken across studies and fit into the same model.
CPM, conditioned pain modulation; CPT, cold pain threshold; HPT, heat pain threshold; PDT, pain detection threshold; PPT, pain pressure detection threshold; QST, quantitative sensory testing; TS, temporal summation.
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compared directly because they are measured through different
scales. However, weaker associations in adjusted analysesmight
be expected in light of the cross-sectional associations between
QST and outcome measures at baseline,30,34,98 and the well-
recognised prediction of an outcome measure by its baseline
value. Significant outcome prediction by QST in adjusted
analyses suggests a direct effect of pain hypersensitivity on
musculoskeletal outcome.
Pain hypersensitivity has been identified in multiple reports of
chronic pain conditions as an underlying pathophysiology9,92,96
and has been associated with the development of additional
symptoms, such as fatigue and mood disturbance,3 that can
further impact on prognosis.12,109 Quantitative sensory testing
can identify the presence of pain hypersensitivity in people with
OA30,98 and WAD.34 Our findings that QST can predict clinical
outcomes in people with musculoskeletal pain indicate that pain
hypersensitivity could be investigated as a mechanism for worse
prognosis. This is further supported by a recent study,71
published after our database search end-date, showing that
patients with knee OA and higher TS responded poorly to
exercise programs.
Possible mechanisms by which pain hypersensitivity might
lead to worse outcomes include alterations in pain processing,
which can persist despite treatment.7,8,96 Pain hypersensitivity
might also pose a barrier to gaining benefit from current
treatments, for example, by reducing treatment uptake or
engagement.15,51,91 Interventions targeting hypersensitivity
might have benefit across a range of musculoskeletal conditions.
Various QST modalities have been designed to address
different mechanisms of hypersensitivity, body regions, or
medical conditions and therefore might differentially predict
outcome. Pain hypersensitivity may be due to changes in the
peripheral nervous system or CNS. Alterations in pain thresholds
using deep stimuli, such as those used for pressure pain
detection thresholds at sites local to musculoskeletal pathology,
might predominantly reflect peripherally driven pain hypersensi-
tivity. However, dynamic QSTmodalities such as CPMor TSwere
most strongly associated with musculoskeletal pain and disabil-
ity, suggesting a possible role for centrally driven pain hypersen-
sitivity.6 Conditioned pain modulation reflects cerebral processes
that are implicated in depressive or psychological disorders even
in the absence of nociceptive drive.7 Conditioned pain modula-
tion might therefore be associated with psychological mecha-
nisms contributing to chronic musculoskeletal pain. Thermal pain
and pain in response to punctate stimulation are mediated by
cutaneous nerves, rather than those localised within musculo-
skeletal tissues. We found that thermal modalities in general, and
cold pain thresholds in particular, were associated with pain-
related disability. Data leading to these conclusions were
predominantly from studies of whiplash-related pain and
disability,34 and condition-specific injury mechanisms might be
responsible for disturbances to the nervous system that differ
between conditions. Further research might explore whether
a contribution of thermal QSTmodalities toworst outcomesmight
also apply to other musculoskeletal diagnoses.
Centrally driven pain hypersensitivity has also been associated
with reduced pain detection thresholds at sites remote from the
site of pathology,45,68,87 whereas increased sensitivity at the site
of pathology might reflect peripheral sensitisation alone plus
augmentation by central sensitisation.98 Our findings that
hypersensitivity at a remote site can predict worse musculoskel-
etal outcomes further support a contribution from central
sensitisation. However, pain thresholds at the site of clinical pain
also predicted outcomes, and a contribution of peripheral
sensitisation to prognosis deserves further study.
Interpretation of our findings is subject to a number of
limitations. Outcome prediction can be influenced by the type
of therapeutic intervention that participants receive, and the effect
of treatments on pain hypersensitivity cannot be determined from
the available data. We found significant heterogeneity between
studies in several of our subgroup analyses, suggesting that
factors additional to those explored here might influence the
ability of QST to predict musculoskeletal outcomes. Funnel plots
displayed significant asymmetry suggesting possible publication
bias, particularly for adjusted analyses. However, 26 of the 37
reports were judged to be of low risk of bias and the remaining
studies of only moderate risk. Sensitivity analyses showed that
the levels of bias did not have a significant effect on our main
findings. Our search strategy was intentionally broad, but it
remains possible that not all relevant studies have been identified.
Small numbers of studies and participants limit our ability to
exclude differences between some subgroups, and our use of
a small number of studies in several analyses might limit
generalisability. The current meta-analyses suggest relatively
weak predictive ability81 for QST, with correlations only some-
times and marginally above 0.30, a threshold considered to be
clinically meaningful.84 However, what consists a meaningful
deviation from that threshold was not established, and analyses
regarding the magnitude of those deviations were not performed.
Inferences in relation to pooled predictive values must be drawn
with caution. A systematic review with meta-analysis of cross-
sectional studies48 also indicated that pain detection thresholds
might not present a clinically important correlation with pain or
disability in spinal pain. However, the significant association even
in adjusted analyses between QST and musculoskeletal out-
comes might suggest underlying mechanisms and potential
targets for intervention. Other prognostic factors, including
psychological factors such as depression or anxiety14 and
maladaptive beliefs such as catastrophizing or fear avoidance,26
might complement outcome prediction by QST.
Identifying which patients might be at particular risk of poor
outcome is important to identify those who are most likely to
benefit from treatment. Quantitative sensory testing modalities
with stimuli applied at the site of clinical pain, dynamic modalities
such as CPM and TS, and thermal pain detection thresholds
seemed to have the greatest potential. PPTs have advantages of
ease of application in clinical settings, low cost, and high user and
patient acceptability. Further refinement of QST and adoption of
standardised QST protocols are recommended. We noted
important methodological variation between published studies,
particularly reflected by the range of stimulus types used in
dynamic modalities. Studies which used blunt pressure as
a testing stimulus and hand immersion in cold water as
a conditioning stimulus contributed most to evidence that CPM
can predict musculoskeletal outcomes. However, available data
did not enable us to draw robust conclusions on superiority
between different stimulus types for TS. Additional confirmatory
research is required in larger andmore homogenous populations,
inside and outside themusculoskeletal spectrum. Translation into
clinical practice requires also feasibility in clinical contexts,
acceptability to patients, and evidence that implementation
improves patient outcomes. Future studies should aim to define
reliability of specific QST approaches and establish clinically
meaningful thresholds in specific pathologies to translate QST
from a research tool into a clinical decision aid formusculoskeletal
conditions.
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In conclusion, we have shown that QST, an index of pain
hypersensitivity, can predict worse musculoskeletal outcomes of
pain, disability, and negative affect. Our findings are consistent
with important contributions from hypersensitivity to outcome,
and reducing pain hypersensitivity has potential to improve
outcome for people with musculoskeletal conditions.
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